These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8733410)

  • 21. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis.
    Gupta PK; Luniya AK; Gupta NK; Tiwari ML
    Indian J Chest Dis Allied Sci; 1983; 25(2):152-4. PubMed ID: 6197367
    [No Abstract]   [Full Text] [Related]  

  • 22. Tuberculosis in people with HIV.
    Bellamy R
    Clin Evid; 2005 Dec; (14):858-68. PubMed ID: 16620440
    [No Abstract]   [Full Text] [Related]  

  • 23. Thiacetazone skin reaction in Papua New Guinea.
    Naraqi S; Temu P
    Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
    Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
    Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
    Okwera A; Whalen C; Byekwaso F; Vjecha M; Johnson J; Huebner R; Mugerwa R; Ellner J
    Lancet; 1994 Nov; 344(8933):1323-8. PubMed ID: 7526098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug regimen for tuberculosis without thiacetazone and streptomycin.
    Biddulph J
    Lancet; 1991 May; 337(8750):1174. PubMed ID: 1709250
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe cutaneous eruptions caused by thiacetazone used to treat tuberculosis in Rio Grande do Sul, Brazil. Public Health Dermatology Team, Tuberculosis Team, and Epidemiologic Control Unit, Rio Grande do Sul State Department of Health.
    Bull Pan Am Health Organ; 1981; 15(2):113-20. PubMed ID: 6173089
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiacetazone reactions.
    Munthali MM; Warndoff DK; Koka CW; Glynn JR; Salaniponi FL
    Trans R Soc Trop Med Hyg; 1995; 89(2):238. PubMed ID: 7539955
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa.
    Pozniak AL; MacLeod GA; Mahari M; Legg W; Weinberg J
    AIDS; 1992 Aug; 6(8):809-14. PubMed ID: 1384557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Valencia ME; Moreno V; Laguna F; González-Lahoz JM
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe skin eruptions caused by thioacetazon in the treatment of tuberculosis in the state of Rio Grande do Sul, Brazil. Secretary of Health of the State of Rio Grande do Sul].
    Bol Oficina Sanit Panam; 1981 Jan; 90(1):10-18. PubMed ID: 6163442
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of tuberculosis in developing countries.
    Elliott AM; Mwinga AG; Foster SD
    Lancet; 1995 Oct; 346(8982):1098-9. PubMed ID: 7564805
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early experiences with Thiacetazone in Germany].
    Blaha H
    Med Welt; 1974 May; 25(20):915-6. PubMed ID: 4135989
    [No Abstract]   [Full Text] [Related]  

  • 38. Dermatological hypersensitivity to thiacetazone.
    Ravindran P; Joshi M
    Indian J Chest Dis; 1974 Jan; 16(1):58-60. PubMed ID: 4138156
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.
    Lehloenya RJ; Dheda K
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):475-86. PubMed ID: 22512756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous sensitivity to thiacetazone.
    Fegan D; Glennon J
    Lancet; 1991 Apr; 337(8748):1036. PubMed ID: 1708068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.